Organization | The Guthrie Clinic

The Guthrie Clinic Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Sayre PA United States (1942)

Organization Overview

First Clinical Trial

2009

NCT00961090

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

The Guthrie Clinic

Active Ingredients

Drugs in Phase 4 Trials (4)

dexamethasone (1 trial)

fentanyl (Innovar) (1 trial)

olanzapine (zyprexa) (1 trial)

ticagrelor (brilinta) (1 trial)

Drugs in Phase 2 Trials (5)

aminolevulinic acid (levulan) (1 trial)

bupivacaine (Exparel) (1 trial)

ropivacaine (naropin) (1 trial)

sitagliptin (januvia) (1 trial)

sucroferric oxyhydroxide (Venofer) (1 trial)

Drugs in Other Trials (1)

iohexol (Omnipaque) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia, Iron-Deficiency (Phase 2)

Atrial Fibrillation (Phase 2)

Glioblastoma (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 10